Revvity, Inc. RVTY

Company Overview

Revvity, Inc. is a U.S.-based life sciences and diagnostics company that develops technologies, instruments, software, assays, and services used in biomedical research, clinical diagnostics, reproductive health, and applied testing markets. The company operates primarily within the healthcare, biotechnology, pharmaceutical, and laboratory services industries. Revvity was formerly known as PerkinElmer, Inc. and adopted the Revvity name in 2023 following a strategic repositioning toward life sciences and diagnostics after divesting several non-core industrial and applied businesses.

The company’s primary revenue drivers include laboratory instruments, diagnostics platforms, reagent kits, informatics software, genomic and cellular analysis technologies, and contract laboratory services. Revvity serves pharmaceutical and biotechnology companies, hospitals, clinical laboratories, academic institutions, and government agencies. Its positioning is supported by a broad installed base of analytical instruments, recurring consumables revenue, and integration across diagnostics, imaging, genomics, and informatics workflows. Public filings and investor materials indicate the company has increasingly focused on higher-growth and higher-margin healthcare-related markets, particularly precision medicine, reproductive health, and translational research.